Your Article Summary
Committed to quality and safety ?EUR Cognis starts voluntary REACH registration of its pharmaceutical excipie
Corporate News Releases - The Healthcare Sales & Marketing Network, 10/06/08
The European Union's REACH chemical legislation also affects the pharmaceutical industry, as it covers all substances for synthesis or processing used in the manufacture of pharmaceuticals. To offer its customers the best possible service, Cognis is submitting its complete range of pharmaceutical excipients and products for inclusion in the pre-registration process. This step ensures that Cognis Nutrition & Health will be able to offer an uninterrupted supply of these products.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
Heinrich Wieland Prize 2009 awarded for outstanding achievements in the synthesis of key natural products
Boehringer Ingelheim, 10/30/09
Nobel Prize team includes three hospital researchers
American Hospital Association News, 10/14/09
Call for Applications: The Amgen Award for Science Teaching Excellence
Amgen, 11/05/09
Article Search
Sponsor


See Latest Articles


